SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Transkaryotic(tktx)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Souze who wrote (44)6/9/2000 6:19:00 PM
From: Snooker  Read Replies (1) of 122
 
There's also this:


Boston, June 9 (Bloomberg) -- Transkaryotic Therapies Inc. scored a preliminary victory in its patent battle against Amgen Inc., the world's biggest biotechnology company, although the trial over whether Transkaryotic can sell a rival version of Amgen's anemia drug Epogen will continue.

Judge William G. Young said he wouldn't consider one of Amgen's several patent claims and part of another in dispute in the case. However, Young turned down Transkaryotic's request for a ruling that the company didn't infringe on any of Amgen's patents.

The judge said the ruling was preliminary. ``It simply says they cannot win today,'' Young said. Thousand Oaks, California-based Amgen sued Cambridge, Massachusetts-based Transkaryotic and Aventis SA predecessor Hoechst Marion Roussel Inc. in April 1997, alleging they misappropriated
Amgen inventions protected by five U.S. patents for making Epogen, a version of the human protein
erythropoietin that generates about $4 billion in annual sales.
Amgen reported total 1999 sales of its products at $3.34 billion. Transkaryotic reported sales of $3.87 million for 1999. Aventis reported $13.4 billion in 1999 sales.
Amgen shares fell 3 1/16 to 62 5/8 and Transkaryotic shares rose 11 3/16 to 42 7/8 before being halted.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News